Market Place
Sourcing Support
All News #Library
Biotech
Chugai Drops Only AI-Assisted Antibody From Pipeline
30 Jan 2026 //
FIERCE BIOTECH
JPM26: Chugai Chases New Science And Name Recognition
16 Jan 2026 //
FIERCE BIOTECH
Roche Axes 4 Chugai Solid Tumor Assets In Early-Phase Clear-Out
24 Oct 2025 //
FIERCE BIOTECH
Chugai & Gero Enter into Agreement for Age-Related Diseases
08 Jul 2025 //
PRESS RELEASE
Roche`s Chugai turns to Swiss biotech Araris for ADC deal
10 Jan 2025 //
FIERCE BIOTECH
Chugai in-licenses RNAi therapeutic zilebesiran for hyp.high cardiovascular risk
20 Apr 2024 //
PHARMABIZ
Chugai: Piasky (crovalimab) for Paroxysmal Nocturnal Hemoglobinuria approved in Japan
26 Mar 2024 //
PRESS RELEASE
Chugai seeks Japanese approval for crovalimab to treat PNH
15 Jun 2023 //
PHARMABIZ
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.